ArticleMolecular and clinical oncology2024

Circulating tumor DNA serial monitoring of relapse and responses to tislelizumab immunotherapy as second‑line monotherapy for metastatic esophageal squamous cell carcinoma: A prospective study.

Qiong He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.